This study explored the molecular mechanism of comorbidity between RA and cervical cancer by integrating transcriptomic analysis and validating it in individuals with cervical cancer combined with RA, and successfully identified three key hub genes (SPP1, LYZ, and MCM5), which were significantly upregulated in both RA and cervical cancer. This evidence concerns the gene MCM5 and cervical carcinoma.